Dallas, Texas (August 19, 2011) – StockGuru Shines its Spotlight on SAIL Capital Partners which has announced that its portfolio company CNS Response, Inc. (OTCBB: CNSO), achieved top line results from an analysis of physician reports and health records released by a high-volume managed care psychiatric clinic which services several of the nation’s largest managed care networks. The Company closed unchanged on August 18, 2011, at $0.25, and did not trade. The fifty-two week range is $0.60 – 0.15.
The initial analysis of 128 records of patients treated for mental health conditions from 2003 to mid-2011 represents cases in which physicians received CNS Response’s PEER Outcome Reports™ for their patients. The analysis found that physicians who had access to PEER Outcomes reported a reduction in the number of medications that had to be tried on a patient before achieving a successful outcome, otherwise known as trial-and-error pharmacotherapy.
Among the findings of the analysis:
- 16 patients, or 13%, actually required no medications at all.
Of the remaining 112 patients who required medications, when their physicians had access to the PEER Outcome Report:
- 88% of the patients achieved “much improved” or “very much improved” health outcomes.
In addition to the initial payer analysis, CNS Response announced that a detailed technology assessment of CNS Response’s Referenced-EEG® (rEEG®), the company’s original physician-developed database, was recently completed by OptumHealth. A unit of UnitedHealthcare, OptumHealth approved rEEG as an “Emerging Technology.” The Technology Assessment is now available online to registered United/OptumHealth network providers, and will be posted to www.ubhonline.com/html/clinResources.html on August 26. It will also be available in the physician section of the CNS Response website.
Since January 1, 2010, the company has also received 313 physician rating reports, with 94 percent of physicians indicating the information provided through the CNS Response PEER Outcome Report was “helpful” and 47 percent indicating the information was “essential” in treating their patients.
“These results were achieved by physicians, not a report,” said George Carpenter, CNS Response CEO. “It’s a basic principle of medicine that physicians who exchange outcome information achieve better — sometimes dramatically better — results than those who don’t.
CNS Response is backed by private investment firm, SAIL Capital Partners. Alan Sellers, Senior Partner with SAIL Capital Partners, noted, “CNS Response was an early SAIL investment where we were experimenting at the horizon of defining a medical version of cleantech. We are pleased that our faith in this efficient path-breaking technology has been rewarded by medical system adoption.”
About CNS Response
CNS Response provides reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for their mental disorder. The company recently launched the Psychiatric EEG Evaluation Registry, or PEER Online™, a new registry and cloud-based reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through an EEG. PEER Online builds on the company’s original physician-developed database, Referenced-EEG® (rEEG®). Avoiding trial and error pharmacotherapy, the dominant approach for psychiatric treatment, is the objective of PEER Online™.
To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.cnsresponse.com. Medical professionals interested in learning more can contact CNS Response at [email protected].
ABOUT SAIL
SAIL Capital Partners (www.sailcapital.com) is a cleantech investment firm with unique global insight into technologies, markets and opportunities. Drawing on decades of experience in cleantech and in growing successful businesses, the SAIL team invests in companies with proven technologies, visionary leadership, demonstrated revenue and profit growth potential. SAIL has invested in a number of the world’s leading cleantech companies, including: FlexEnergy, The Cleantech Group, Xtreme Power, Enerpulse, Kokam Advanced Batteries, M2 Renewables and WaterHealth International.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.
To view this StockGuru Spotlight, please visit: http://stockguru.com/category/latest-spotlights/
To get free alerts on this and other similar stocks, please register here:
What is the StockGuru Spotlight?
Many companies covered in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, StockGuru strives to cover companies in The StockGuru Spotlight that are worth of our readers’ attention.
StockGuru looks for potential break-out candidates in The StockGuru Spotlight. Many of these companies have had recent news and appear to be getting the attention of investors. StockGuru does not typically feature companies in The StockGuru Spotlight that are compensating StockGuru for this coverage. There are times when StockGuru covers a stock in The StockGuru Spotlight that had previously compensated Stockguru. Where that is the case, a proper disclosure is included below. StockGuru and its partners, employees and writers never hold shares, short positions, warrants or any other current position in a stock featured in The StockGuru Spotlight.
To feature a company in The StockGuru Spotlight please contact the Publisher at [email protected]. If our reader is a key person for a publicly traded company, StockGuru can consider that company for either a StockGuru Spotlight or a StockGuru Profile. Please contact the StockGuru Publisher John Pentony at this email address: [email protected].
Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. StockGuru is occasionally compensated for coverage. When this is the case, SG clearly indicates this with a disclosure of all compensation received in the past and present. Additionally SG also discloses any anticipated compensation in the future. Compensation is typically in cash. Sometimes a company pays SG in restricted shares. Pentony Enterprise and its associated companies does not take free trading shares for any reason at anytime. StockGuru is not a registered investment adviser or a broker-dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
John Pentony, Publisher, Stockguru.com
Tel: +1 469 252 3031
e-mail: [email protected]